What coverage agrees on
Across the reporting, the central facts are consistent: a New Hampshire patient lived with a pig kidney for 271 days before a human transplant, and the case is being presented as important for xenotransplantation research.
Tim Andrews lived with a transplanted pig kidney for 271 days before receiving a human donor kidney.
The case was described as the longest dialysis-free survival after porcine kidney xenotransplantation.
Andrews said he took part to help advance medical research and aid humanity.
Doctors said the pig kidney served as a temporary bridge while he awaited a human organ.
Researchers said the case adds data for future xenotransplantation trials.
One report said the kidney eventually suffered blood vessel damage and was removed.
A quick read on shared facts, changing details, and different emphasis.
Across the reporting, the central facts are consistent: a New Hampshire patient lived with a pig kidney for 271 days before a human transplant, and the case is being presented as important for xenotransplantation research.
Some details remain limited in the supplied coverage, including the full clinical course beyond the reported transplant swap and how widely the findings will change future practice.
Swipe through the perspectives. Labels describe coverage framing, not truth or quality.
Supportive coverage highlights the record-setting 271-day survival and the patient's stated wish to help science and humanity. It presents the case as evidence that a pig kidney can support renal function long enough to bridge a patient to a human transplant. The emphasis is on the medical milestone and its value for advancing xenotransplantation. The reports describe it as the longest dialysis-free survival of its kind.
Neutral coverage is limited to the source that contained only browser-verification text and no reportable medical details. Because that material did not include substantive reporting, it does not add factual claims about the transplant case. The other neutral-framed reports focus on the procedure, the 271-day survival, and the later human kidney transplant. Overall, this grouping contributes little beyond confirming that not every source supplied usable story text.
The latest eight dated reports, from earliest to newest.
GreekReporter.com
newskarnataka.com
Attributed summaries from official party channels. These are claims, not independent reporting or fact checks.
Scan each source take, then open the original article.
A New Hampshire man survived for a record 271 days with a transplanted pig kidney at Mass General Brigham before receiving a human donor kidney. Tim Andrews, 68, stated he undertook the procedure to help advance medical research despite believing he was near death. Published findings in The Lancet indicate the case demonstrates that xenotransplantation can safely support renal function and act as a bridge to human organ transplants.
A New Hampshire resident lived for a record 271 days with a transplanted pig kidney before transitioning to a human kidney transplant. Tim Andrews, who received the organ at age 66 in January 2025, stated he wanted to aid humanity through the procedure. According to a study published in The Lancet and statements from Mass General, the case marks the longest dialysis-free survival following porcine kidney xenotransplantation.
NBC 7 San Diego reports that an American patient named Tim Andrews survived for a record 271 days using a transplanted pig kidney before receiving a human donor organ. Researchers highlighted the case in The Lancet as a significant advancement in xenotransplantation, which could help address the severe shortage of human organs. According to hospital statements, the pig kidney successfully supported renal function without the need for dialysis during that period.
Deseret News reports that a patient named Tim Andrews lived for 271 days with a genetically altered pig kidney before receiving a human organ. According to doctors at Mass General Brigham, the case demonstrates that xenotransplantation can serve as a vital bridge for patients facing end-stage kidney failure amidst a severe organ shortage. The article details historical context on animal organ research and ongoing ethical debates surrounding the practice.
This source presents a blocking message indicating that bot detection was triggered while attempting to browse the page. It instructs users to ensure cookies and JavaScript are enabled to regain access. The article text contains no reporting on the medical procedure itself or the patient who received the transplant. Because the content is entirely technical boilerplate related to browser verification, no factual medical claims from the central story can be confirmed or summarized from this specific text.
A 66 year old man named Tim Andrews lived with a genetically modified pig kidney for nine months before transitioning to a human donor kidney in a world first procedure. Doctors reported the animal organ served as a temporary bridge for end stage kidney disease while awaiting a human organ. Researchers published their findings in the Lancet medical journal detailing the successful 271 day survival period without dialysis. Experts noted that xenotransplantation could help address severe human organ shortages despite ongoing challenges and the need for further safety research.
Researchers reported that a genetically edited pig kidney functioned for 271 days in a New Hampshire patient before being replaced by a human kidney. Tim Andrews received the organ from a Yucatan miniature pig at Massachusetts General Hospital in January 2025. Scientists noted that while the pig kidney eventually suffered blood vessel damage and was removed, the case provides vital data for future clinical trials on xenotransplantation.
Gigazine reports that Tim Andrews, a patient with end-stage kidney disease, survived for 271 days after receiving a genetically edited pig kidney at Massachusetts General Hospital on January 25, 2025. Although a biopsy showed early rejection that was successfully treated, the organ later developed microvessel inflammation, leading to its removal when a human donor kidney became available. Researchers noted that no new human tissue antibodies were detected, though they cautioned that the success relied on intensive care and represents a single uncontrolled case.